methoxy-morpholinyl-doxorubicin has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clausen, OP; De Angelis, P; Lehne, G; Rugstad, HE | 1 |
| Amboldi, N; Ballinari, D; Collavo, D; Quintieri, L; Rosato, A; Vizler, C; Zanovello, P | 1 |
2 other study(ies) available for methoxy-morpholinyl-doxorubicin and Liver Neoplasms
| Article | Year |
|---|---|
Differential resistance to anthracyclines in P-glycoprotein-expressing human hepatoma cells.
Topics: Aclarubicin; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cyclosporins; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Humans; Liver Neoplasms; Tumor Cells, Cultured | 1998 |
Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastases.
Topics: Adolescent; Animals; Antibiotics, Antineoplastic; Doxorubicin; Humans; Immunotherapy, Adoptive; Immunotoxins; Interleukin-2; Killer Cells, Lymphokine-Activated; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Mice; Tumor Cells, Cultured | 1999 |